Matinas Biopharma Holdings, Inc. (MTNB): Price and Financial Metrics
MTNB Price/Volume Stats
| Current price | $0.60 | 52-week high | $21.50 |
| Prev. close | $0.57 | 52-week low | $0.48 |
| Day low | $0.56 | Volume | 60,600 |
| Day high | $0.60 | Avg. volume | 1,329,257 |
| 50-day MA | $0.61 | Dividend yield | N/A |
| 200-day MA | $5.15 | Market Cap | 3.04M |
MTNB Stock Price Chart Interactive Chart >
Matinas Biopharma Holdings, Inc. (MTNB) Company Bio
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections.
MTNB Price Returns
| 1-mo | N/A |
| 3-mo | -81.54% |
| 6-mo | -92.91% |
| 1-year | -93.67% |
| 3-year | -98.21% |
| 5-year | -99.18% |
| YTD | 17.65% |
| 2024 | -95.28% |
| 2023 | -56.76% |
| 2022 | -50.50% |
| 2021 | -25.74% |
| 2020 | -40.09% |
Loading social stream, please wait...